Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALX1-11 in postmenopausal osteoporosis (OLES)
NCT00172133Phase 3Completed
- Sponsor
- Takeda
- Start
- Oct 2001
- Primary completion
- Apr 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 8
01
Overview
A Phase 3 trial of parathyroid hormone 1-84 in postmenopausal osteoporosis, sponsored by Takeda. Started Oct 2001; status: completed.
02
Drugs
parathyroid hormone 1-84
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00172133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00172133.